Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/10/2012US8153696 Medicinal preparation particularly for the treatment of slipped discs hernias
04/10/2012US8153695 Methods for inhibiting post-surgical adhesions
04/10/2012US8153694 Cyclopropanecarboxylic acid compound
04/10/2012US8153693 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
04/10/2012US8153692 Oral preparation for preventing or improving skin dryness
04/10/2012US8153691 Method for preparing compositions for preventing or treating inflammatory bowel disease
04/10/2012US8153690 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management
04/10/2012US8153689 Pleuromutilin derivatives for the treatment of diseases mediated by microbes
04/10/2012US8153688 Esters of 2-phenylalkanenitriles and antifungal compositions containing them
04/10/2012US8153687 Gallium complexes with polyalcohols and methods of use
04/10/2012US8153686 Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
04/10/2012US8153684 Use of equol for treating androgen mediated diseases
04/10/2012US8153683 Methods of treatment using a prodrug of an excitatory amino acid
04/10/2012US8153682 Sulfonamides as TRPM8 modulators
04/10/2012US8153681 Method of treating epilepsy by administering 5-(4{[(2-fluorophenyl)methyl]oxy}phenyl)prolinamide
04/10/2012US8153680 Alkyl indole-3-carbinol-derived antitumor agents
04/10/2012US8153679 Radiolabelled inhibitors of the glycine 1 transporter
04/10/2012US8153678 Process for preparing A 3-pyrrole substituted 2-indolinone malate salt
04/10/2012US8153677 Substituted pyrazolylamide compounds useful as glucokinase activators
04/10/2012US8153676 Use of compounds of formula A-R-Xo pharmaceutically acceptable salts thereof for producing a pharmaceutically preparations
04/10/2012US8153675 Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
04/10/2012US8153674 Organic compounds
04/10/2012US8153673 Metalloproteinase inhibitors
04/10/2012US8153672 Polymorphic forms of deferasirox (ICL670A)
04/10/2012US8153671 Heterotetracyclic compounds as TPO mimetics
04/10/2012US8153670 Factor Xa inhibitors
04/10/2012US8153669 Quaternary ammonium salts as M3 antagonists
04/10/2012US8153668 Polymorphic forms of (S)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamate
04/10/2012US8153667 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
04/10/2012US8153666 Compounds having analgesic and/or immunostimulant activity
04/10/2012US8153664 thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failures and cancer
04/10/2012US8153663 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives
04/10/2012US8153662 Heterocycles substituted pyridine derivatives and antifungal agent containing thereof
04/10/2012US8153661 Controlled delivery system
04/10/2012US8153660 Piperidyl-propane-thiol CCR3 modulators
04/10/2012US8153659 4′-O-substituted isoindoline derivatives and compositions comprising and methods of using the same
04/10/2012US8153658 Piperidine derivative or salt thereof
04/10/2012US8153657 Dopamine-, norepinephrine- and serotonin-transporter-selective heterocyclic compounds and their therapeutic applications
04/10/2012US8153655 Compositions useful as inhibitors of voltage-gated sodium channels
04/10/2012US8153653 Amido-tropane derivatives
04/10/2012US8153652 Fab I inhibitors
04/10/2012US8153651 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
04/10/2012US8153650 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy
04/10/2012US8153649 3-aminoimidazo 1,2-A pyridine derivatives having an SGLT1- and SGLT2-inhibiting action for the treatment of type 1 and type 2 diabetes
04/10/2012US8153648 Solid and crystalline dutasteride and processes for preparation thereof
04/10/2012US8153647 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
04/10/2012US8153645 Treating pain using selective antagonists of persistent sodium current
04/10/2012US8153644 Diacylglycerol acyltransferase inhibitors
04/10/2012US8153643 Quinazoline derivatives
04/10/2012US8153642 Quinazolines useful as modulators of ion channels
04/10/2012US8153641 Compounds and methods for kinase modulation, and indications therefor
04/10/2012US8153640 Reverse transcriptase inhibitors; use against HIV with drug resistance to NNRTI's (Non Nucleoside Reverse Transcriptase Inhibitor drugs); Diaryl Pyrrolo(2,3-d)pyrimidines, diaryl purines, diaryl v-triazolo(4,5-d)pyrimidines
04/10/2012US8153639 Substituted thieno- and furano- fused pyrimidines as PI3K inhibitors
04/10/2012US8153638 Metabotropic glutamate-receptor-potentiating isoindolones
04/10/2012US8153637 Phenyl-alkyl piperazines having TNF-modulating activity, preparation method, and therapeutic use thereof
04/10/2012US8153636 Pyridyl derivatives and their use as therapeutic agents
04/10/2012US8153635 Compounds and compositions as modulators of GPR119 activity
04/10/2012US8153634 Carbinol derivatives having cyclic linker
04/10/2012US8153633 Phthalazine compounds, compositions and methods of use
04/10/2012US8153632 Oxygen linked pyrimidine derivatives
04/10/2012US8153631 Triazole compounds and uses related thereto
04/10/2012US8153630 of Aurora-2 (Aurora-A) protein kinase; anticancer; 6-(pyrazolylamino)-4-pyrimidine carboxamides; Methyl 2-(4-cyclopropanecarboxamidophenylsulfanyl)-5-amino-6-(5-methylpyrazol-3-ylamino)-4-pyrimidinecarboxylate
04/10/2012US8153629 Pharmaceutical compounds
04/10/2012US8153628 Pyrazolyl substituted xanthines
04/10/2012US8153627 Quinazoline linked pyrrolo[2,1-C][1, 4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof
04/10/2012US8153626 Substituted diazepine sulfonamides as bombesin receptor subtype-3 modulators
04/10/2012US8153625 Nitrogen-containing heterocyclic compounds and medicinal use thereof
04/10/2012US8153624 Compounds and methods for modulating FXR
04/10/2012US8153623 Compounds
04/10/2012US8153622 8-substituted benzoazepines as toll-like receptor modulators
04/10/2012US8153621 phentermine and a selective 5HT-2C receptor agonist such as lorcaserin; decrease food intake
04/10/2012US8153620 Photoactive metal nitrosyls for blood pressure regulation and cancer therapy
04/10/2012US8153619 Diazonamide analogs
04/10/2012US8153618 Bridged polycyclic compound based compositions for topical applications for pets
04/10/2012US8153617 Bridged polycyclic compound based compositions for coating oral surfaces in humans
04/10/2012US8153616 Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
04/10/2012US8153615 Synthesis of glycerolipid carbamates and dicarbamates and their use as an antitumor compounds
04/10/2012US8153614 Treatment of osteoarthritis
04/10/2012US8153613 Barrier film-forming germicidal composition for controlling mastitis
04/10/2012US8153611 Use of sulfated oligosaccharides as slimming cosmetic ingredients
04/10/2012US8153610 T cell clones; drug screening
04/10/2012US8153609 Purine nucleotide derivatives
04/10/2012US8153608 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
04/10/2012US8153607 Transcription factor decoys and use thereof
04/10/2012US8153606 Treatment of apolipoprotein-A1 related diseases by inhibition of natural antisense transcript to apolipoprotein-A1
04/10/2012US8153604 CNS-tumor treatment method and composition
04/10/2012US8153601 Azithromycin-containing aqueous pharmaceutical composition and a method for the preparation of the same
04/10/2012US8153600 Enhancing non-denatured collagenous tissues to increase resistance to tearing, fissuring, rupturing, and/or delamination via genipin crosslinking treatment; improving fatigue resistance
04/10/2012US8153593 Transglutaminase inhibitors and methods of use thereof
04/10/2012US8153591 Protein biomaterials and biocoacervates and methods of making and using thereof
04/10/2012US8153589 JNK3 as a target for the treatment of angiogenesis-related diseases
04/10/2012US8153588 Methods useful in the treatment of bone resorption diseases
04/10/2012US8153581 Process for producing an injectable medicament preparation
04/10/2012US8153558 Method of improving grass quality
04/10/2012US8153443 Characterization of the CBir1 antigenic response for diagnosis and treatment of Crohn's disease
04/10/2012US8153384 Marks as modifiers of the p53 pathway and methods of use
04/10/2012US8153172 Composition to enhance the bioavailability of curcumin
04/10/2012US8153161 Medicament-containing particle and a solid preparation containing the particle
04/10/2012US8153159 Modafinil modified release pharmaceutical compositions
04/10/2012US8153152 Oral drug delivery system
1 ... 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 ... 7860